Search Results - "Rogstad, Sarah"

Refine Results
  1. 1

    Multi-Attribute Method for Quality Control of Therapeutic Proteins by Rogstad, Sarah, Yan, Haoheng, Wang, Xiaoshi, Powers, David, Brorson, Kurt, Damdinsuren, Bazarragchaa, Lee, Sau

    Published in Analytical chemistry (Washington) (19-11-2019)
    “…Recent advances in high resolution mass spectrometry (MS) instrumentation and semi-automated software have led to a push toward the use of MS-based methods for…”
    Get full text
    Journal Article
  2. 2

    Improved Precision of Proteomic Measurements in Immunoprecipitation Based Purifications Using Relative Quantitation by Rogstad, Sarah M, Sorkina, Tatiana, Sorkin, Alexander, Wu, Christine C

    Published in Analytical chemistry (Washington) (07-05-2013)
    “…Mass spectrometry coupled immunoprecipitation (MS-IP) studies are useful in identifying and quantitating potential binding partners of a target protein…”
    Get full text
    Journal Article
  3. 3

    Comparison of Traditional 2-AB Fluorescence LC-MS/MS and Automated LC-MS for the Comparative Glycan Analysis of Monoclonal Antibodies by Schiel, John E, Rogstad, Sarah M, Boyne, 2nd, Michael T

    Published in Journal of pharmaceutical sciences (01-08-2015)
    “…Monoclonal antibody therapeutics are a heterogeneous mixture of glycoforms. Multiple methods exist for defining the glycan composition and relative abundance…”
    Get more information
    Journal Article
  4. 4
  5. 5

    An etanercept O-glycovariant with enhanced potency by Biel, Thomas G., Faison, Talia, Matthews, Alicia M., Zou, Guozhang, Ortega-Rodriguez, Uriel, Pegues, Melissa A., Azer, Nicole, Gomez, Fabiola, Johnson, Sarah, Rogstad, Sarah, Chen, Kang, Xie, Hang, Agarabi, Cyrus, Rao, V. Ashutosh, Ju, Tongzhong

    “…Most therapeutic proteins are glycosylated with N-glycans and/or O-glycans. N-glycans on therapeutic proteins have been extensively studied for their control…”
    Get full text
    Journal Article
  6. 6

    The Use of Mass Spectrometry in Therapeutic Protein Biologics License Applications: A Retrospective Review Revisited by Mans, Jamie, Oyugi, Mercy, Asmelash, Bethel, Sommers, Cynthia, Rogstad, Sarah

    “…Biologic license applications (BLAs) for 93 therapeutic proteins approved between 2016 and 2020 were analyzed for use of mass spectrometry (MS) as a follow up…”
    Get full text
    Journal Article
  7. 7

    Method validation and new peak detection for the liquid chromatography-mass spectrometry multi-attribute method by Oyugi, Mercy, Wang, Xiaoshi, Yang, Xiangkun, Wu, Di, Rogstad, Sarah

    “…The multi-attribute method (MAM) is a liquid chromatography-mass spectrometry (LC-MS) peptide mapping technique that has been proposed as a replacement for…”
    Get full text
    Journal Article
  8. 8

    A Retrospective Evaluation of the Use of Mass Spectrometry in FDA Biologics License Applications by Rogstad, Sarah, Faustino, Anneliese, Ruth, Ashley, Keire, David, Boyne, Michael, Park, Jun

    “…The characterization sections of biologics license applications (BLAs) approved by the United States Food and Drug Administration (FDA) between 2000 and 2015…”
    Get full text
    Journal Article
  9. 9

    The role of mass spectrometry in the characterization of biologic protein products by Rathore, Deepali, Faustino, Anneliese, Schiel, John, Pang, Eric, Boyne, Michael, Rogstad, Sarah

    Published in Expert review of proteomics (04-05-2018)
    “…Mass spectrometry (MS) is widely used in the characterization of biomolecules including peptide and protein therapeutics. These biotechnology products have…”
    Get more information
    Journal Article
  10. 10

    Assessment of monoclonal antibody glycosylation: a comparative study using HRMS, NMR, and HILIC-FLD by Shipman, Joshua, Karfunkle, Michael, Zhu, Hongbin, Zhuo, You, Chen, Kang, Patabandige, Milani, Wu, Di, Oyugi, Mercy, Kerr, Richard, Yang, Kui, Rogstad, Sarah

    Published in Analytical and bioanalytical chemistry (01-05-2024)
    “…Monoclonal antibodies (mAbs) represent the largest class of therapeutic protein drug products. mAb glycosylation produces a heterogeneous, analytically…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach by Daniels, Jaclyn R, Cao, Zhijun, Maisha, Mackean, Schnackenberg, Laura K, Sun, Jinchun, Pence, Lisa, Schmitt, Thomas C, Kamlage, Beate, Rogstad, Sarah, Beger, Richard D, Yu, Li-Rong

    Published in Journal of proteome research (04-10-2019)
    “…Variable processing and storage of whole blood and/or plasma are potential confounders in biomarker development and clinical assays. The goal of the study was…”
    Get full text
    Journal Article
  13. 13

    New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study by Mouchahoir, Trina, Schiel, John E, Rogers, Rich, Heckert, Alan, Place, Benjamin J, Ammerman, Aaron, Li, Xiaoxiao, Robinson, Tom, Schmidt, Brian, Chumsae, Chris M, Li, Xinbi, Manuilov, Anton V, Yan, Bo, Staples, Gregory O, Ren, Da, Veach, Alexander J, Wang, Dongdong, Yared, Wael, Sosic, Zoran, Wang, Yan, Zang, Li, Leone, Anthony M, Liu, Peiran, Ludwig, Richard, Tao, Li, Wu, Wei, Cansizoglu, Ahmet, Hanneman, Andrew, Adams, Greg W, Perdivara, Irina, Walker, Hunter, Wilson, Margo, Brandenburg, Arnd, DeGraan-Weber, Nick, Gotta, Stefano, Shambaugh, Joe, Alvarez, Melissa, Yu, X. Christopher, Cao, Li, Shao, Chun, Mahan, Andrew, Nanda, Hirsh, Nields, Kristen, Nightlinger, Nancy, Barysz, Helena Maria, Jahn, Michael, Niu, Ben, Wang, Jihong, Leo, Gabriella, Sepe, Nunzio, Liu, Yan-Hui, Patel, Bhumit A, Richardson, Douglas, Wang, Yi, Tizabi, Daniela, Borisov, Oleg V, Lu, Yali, Maynard, Ernest L, Gruhler, Albrecht, Haselmann, Kim F, Krogh, Thomas N, Sönksen, Carsten P, Letarte, Simon, Shen, Sean, Boggio, Kristin, Johnson, Keith, Ni, Wenqin, Patel, Himakshi, Ripley, David, Rouse, Jason C, Zhang, Ying, Daniels, Carly, Dawdy, Andrew, Friese, Olga, Powers, Thomas W, Sperry, Justin B, Woods, Josh, Carlson, Eric, Sen, K. Ilker, Skilton, St John, Busch, Michelle, Lund, Anders, Stapels, Martha, Guo, Xu, Heidelberger, Sibylle, Kaluarachchi, Harini, McCarthy, Sean, Kim, John, Zhen, Jing, Zhou, Ying, Rogstad, Sarah, Wang, Xiaoshi, Fang, Jing, Chen, Weibin, Yu, Ying Qing, Hoogerheide, John G, Scott, Rebecca, Yuan, Hua

    “…The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Modern analytics for synthetically derived complex drug substances: NMR, AFFF–MALS, and MS tests for glatiramer acetate by Rogstad, Sarah, Pang, Eric, Sommers, Cynthia, Hu, Meng, Jiang, Xiaohui, Keire, David A., Boyne, Michael T.

    Published in Analytical and bioanalytical chemistry (01-11-2015)
    “…Glatiramer acetate (GA) is a mixture of synthetic copolymers consisting of four amino acids (glutamic acid, lysine, alanine, and tyrosine) with a labeled…”
    Get full text
    Journal Article
  16. 16

    Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study by Mouchahoir, Trina, Schiel, John E., Rogers, Rich, Heckert, Alan, Place, Benjamin J., Ammerman, Aaron, Li, Xiaoxiao, Robinson, Tom, Schmidt, Brian, Chumsae, Chris M., Li, Xinbi, Manuilov, Anton V., Yan, Bo, Staples, Gregory O., Ren, Da, Veach, Alexander J., Wang, Dongdong, Yared, Wael, Sosic, Zoran, Wang, Yan, Zang, Li, Leone, Anthony M., Liu, Peiran, Ludwig, Richard, Tao, Li, Wu, Wei, Cansizoglu, Ahmet, Hanneman, Andrew, Adams, Greg W., Perdivara, Irina, Walker, Hunter, Wilson, Margo, Brandenburg, Arnd, DeGraan-Weber, Nick, Gotta, Stefano, Shambaugh, Joe, Alvarez, Melissa, Yu, X. Christopher, Cao, Li, Shao, Chun, Mahan, Andrew, Nanda, Hirsh, Nields, Kristen, Nightlinger, Nancy, Niu, Ben, Wang, Jihong, Xu, Wei, Leo, Gabriella, Sepe, Nunzio, Liu, Yan-Hui, Patel, Bhumit A., Richardson, Douglas, Wang, Yi, Tizabi, Daniela, Borisov, Oleg V., Lu, Yali, Maynard, Ernest L., Gruhler, Albrecht, Haselmann, Kim F., Krogh, Thomas N., Sönksen, Carsten P., Letarte, Simon, Shen, Sean, Boggio, Kristin, Johnson, Keith, Ni, Wenqin, Patel, Himakshi, Ripley, David, Rouse, Jason C., Zhang, Ying, Daniels, Carly, Dawdy, Andrew, Friese, Olga, Powers, Thomas W., Sperry, Justin B., Woods, Josh, Carlson, Eric, Sen, K. Ilker, Skilton, St John, Busch, Michelle, Lund, Anders, Stapels, Martha, Guo, Xu, Heidelberger, Sibylle, Kaluarachchi, Harini, McCarthy, Sean, Kim, John, Zhen, Jing, Zhou, Ying, Rogstad, Sarah, Wang, Xiaoshi, Fang, Jing, Chen, Weibin, Yu, Ying Qing, Hoogerheide, John G., Scott, Rebecca, Yuan, Hua

    “…The multi-attribute method (MAM) was conceived as a single assay to potentially replace multiple single-attribute assays that have long been used in process…”
    Get full text
    Journal Article
  17. 17

    Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett‐burman design for a model monoclonal antibody by Agarabi, Cyrus D., Chavez, Brittany K., Lute, Scott C., Read, Erik K., Rogstad, Sarah, Awotwe‐Otoo, David, Brown, Matthew R., Boyne, Michael T., Brorson, Kurt A.

    Published in Biotechnology progress (01-01-2017)
    “…Linkage of upstream cell culture with downstream processing and purification is an aspect of Quality by Design crucial for efficient and consistent production…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Marketplace Analysis of Conjugated Estrogens: Determining the Consistently Present Steroidal Content with LC-MS by Levy, Michaella J., Boyne, Michael T., Rogstad, Sarah, Skanchy, David J., Jiang, Xiaohui, Geerlof-Vidavsky, Ilan

    Published in The AAPS journal (01-11-2015)
    “…Conjugated estrogens purified from pregnant mares urine has been used as estrogen hormone replacement therapy since 1942. Previously, methods were proposed to…”
    Get full text
    Journal Article